Former chairman of the Department of Obstetrics/Gynecology at Guantanamo Bay, Dr. Joel Match leverages over 40 years of medical experience to provide addiction care and treatment services to patients of Addiction Care and Treatment Centers in Virginia. Dr. Joel Match offers suboxone treatment options through his practice, and speaks about different suboxone products on behalf of pharmaceutical companies.
A common part of medication-assisted treatment (MAT) programs, suboxone aims to ease withdrawal symptoms resulting from opioid addiction treatment. It blends two active ingredients: buprenorphine and naloxone.
Of the two, buprenorphine acts as the primary ingredient. A partial opioid agonist, it acts similarly to other opioids, like heroin or methadone. However, it only allows for partial effects of the drug. Unlike opioids, buprenorphine has a ceiling so that higher doses do not increase the effects of the drug. As a result, the risk of dependency and overdose lowers.
Meanwhile, naloxone is an opioid antagonist, or blocker. It counteracts the effects of buprenorphine by blocking opioid receptors in the brain. This means that people do not experience the high they would otherwise when taking opioids or buprenorphine alone.
Both ingredients play a key role in keeping a person’s daily life normal when on suboxone. The drug manages the pain of opioid withdrawals and helps patients live a normal life while going through treatment. As a person progresses through treatment, they receive increasingly smaller doses of suboxone.